ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
ROBINS-I: инструмент для оценки риска смещения в нерендомизированных исследованиях вмешательств
2016-10-12
SCID: 54.1/ssqkz7v8
Discuss with AI
ROBINS-Icomparative effectivenessnon-randomised studies of interventionsrisk of biassystematic reviews
Figures from the paper
Abstract (AI)
Non-randomised studies of the effects of interventions are critical to many areas of healthcare evaluation, but their results may be biased. It is therefore important to understand and appraise their strengths and weaknesses. We developed ROBINS-I (“Risk Of Bias In Non-randomised Studies - of Interventions”), a new tool for evaluating risk of bias in estimates of the comparative effectiveness (harm or benefit) of interventions from studies that did not use randomisation to allocate units (individuals or clusters of individuals) to comparison groups. The tool will be particularly useful to those undertaking systematic reviews that include non-randomised studies.
Key Findings
1
ROBINS-I is a newly developed tool for assessing risk of bias in non-randomised studies of interventions.
2
ROBINS-I is intended to help users appraise strengths and weaknesses of non-randomised intervention studies.
3
The tool evaluates bias in estimates of comparative effectiveness (harm or benefit) from studies without randomised allocation.
4
The tool is particularly useful for conducting systematic reviews that include non-randomised studies.
Research Object
Non-randomised studies of interventions (studies that did not use randomisation to allocate individuals or clusters to comparison groups)
Research Subject
Risk of bias in estimates of comparative effectiveness (harm or benefit) of interventions and systematic appraisal using the ROBINS-I assessment tool
Publication Details
Publication Date
2016-10-12
Journal
Publisher
ISSN
Cited by
20682
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai4
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials2011
The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants2017
Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal2024
Evaluating non-randomised intervention studies2003
Cited by18
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews2021
RoB 2: a revised tool for assessing risk of bias in randomised trials2019
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews2021
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both2017
Risk‐of‐bias VISualization (robvis): An R package and Shiny web app for visualizing risk‐of‐bias assessments2020
Modifiable Lifestyle Factors for Primary Prevention of CKD: A Systematic Review and Meta-Analysis2020
Quantified Metrics of Gastric Emptying Delay by Glucagon-Like Peptide-1 Agonists: A Systematic Review and Meta-Analysis With Insights for Periprocedural Management2024
Probiotic, prebiotic, synbiotic and fermented food supplementation in psychiatric disorders: A systematic review of clinical trials2024
Online interventions for reducing hate speech and cyberhate: A systematic review2022
The impact of sports participation on psychological health and social outcomes in children and adolescents: a systematic review and update to the “Mental Health through Sport” conceptual model2026
The role of agentic artificial intelligence in healthcare: a scoping review2026
The impact of glucagon-like peptide-1 receptor agonists in the patients undergoing anesthesia or sedation: systematic review and meta-analysis2024
Outpatient Treatment of Low‐risk Pulmonary Embolism in the Era of Direct Oral Anticoagulants: A Systematic Review2020
Effects of mindfulness-based interventions on cognitive impairment in patients with cancer: A systematic review and meta-analysis2025
Efficacy of pharmacological therapies in reducing outflow tract obstruction in patients with obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis2025
The effects of stroboscopic vision training on physical performance in athletes: a systematic review2025
A systematic review and three-level meta-analysis of the effects of stroboscopic training on sport-specific performance2025
Peri‐implant soft tissue phenotype modification and its impact on peri‐implant health: A systematic review and network meta‐analysis2020